GSK
About: In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Employees: 70,200
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
58% more call options, than puts
Call options by funds: $172M | Put options by funds: $109M
2% more repeat investments, than reductions
Existing positions increased: 306 | Existing positions reduced: 301
0.28% less ownership
Funds ownership: 7.8% [Q1] → 7.53% (-0.28%) [Q2]
3% less funds holding
Funds holding: 895 [Q1] → 867 (-28) [Q2]
13% less capital invested
Capital invested by funds: $13.8B [Q1] → $12B (-$1.87B) [Q2]
27% less first-time investments, than exits
New positions opened: 74 | Existing positions closed: 102
29% less funds holding in top 10
Funds holding in top 10: 14 [Q1] → 10 (-4) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for GSK.
Financial journalist opinion
Based on 30 articles about GSK published over the past 30 days